_________
false
פלוריסטם תרפיוטיקס אינק
2
380
PLURISTEM THERAPEUTICS INC
Corporation no:
C12337-2001
8544
Israel Securities Authority
Tel Aviv Stock Exchange
C002
(
Public
)
Reported via MAGNA:
12/06/2018
www.isa.gov.il
www.tase.co.il
Reference:
2018-02-050532
Time of broadcast:
12:55
12:22:40
Immediate Report
Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
Delay the publication of a report
_________
_________
1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.
2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Pluristem Reports Positive Top-Line Results from Its Multinational Phase II Intermittent Claudication Study
IC_Top_line_results_final_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
NASDAQ CM
Date of revision of form structure:
01/05/2018
Address:
Matam Park
5
,
Haifa
31905
ISRAEL
,
Tel:
074-7107171
,
Fax:
074-7107172
E-mail address:
Info@Pluristem.Com
Company site:
www.pluristem.com
Previous names of reporting entity:
Name of the Signatory:
Aberman Zalman
Position of Signatory in the reporting corporation:
Chairman Of The Board & CEO
Name of Employer Company:
Address:
Matam Park
20
,
Haifa
31905
Telephone:
074-7107171
Facsimile:
074-7107172
E-mail:
zami@pluristem.com
2